HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Lodoxamide
Lodoxamida · Lodoxamidum · Unii-spu695od73 · LODOXAMIDE USP/EP/BP · Lodoxamide (U42585E) · Lodoxamide lmpurity 16 · Lodoxamide lmpurity 01 · Lodoxamidum [inn-latin]
Identifikatoren & physikalische Daten
| CAS No. | 53882-12-5 |
|---|---|
| Summenformel | C11H6ClN3O6 |
| Durchschnittliche Molmasse | 311,63 g/mol |
| Monoisotopische Masse | 310,9945126 g/mol |
| SMILES | N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1 |
| InChIKey | RVGLGHVJXCETIO-UHFFFAOYSA-N |
| PubChem CID | 44564 |
| ChEMBL | CHEMBL1201266 |
| ChEBI | CHEBI:135333 |
| DTXSID | DTXSID9057767 |
Chemische & physikalische Eigenschaften
| XLogP | 0,5 |
|---|---|
| Polarare Oberfläche (TPSA) | 157 |
| H-Brücken-Donoren | 4 |
| H-Brücken-Akzeptoren | 7 |
| Frei drehbare Bindungen | 4 |
| Schwere Atome | 21 |
| Formalladung | 0 |
| Komplexität | 489 |
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15 |
| Human Drugs | Breast FeedingLactationMilk, HumanAnti-Allergic AgentsHistamine Antagonists |
| Schmelzpunkt | 212° (dec) |
| Dichte | 1.78±0.1 g/cm3(Predicted) |
| Lagerbedingungen | Store at -20°C |
| Löslichkeit | DMF: 3 mg/mlDMSO: 5 mg/mlPBS (pH 7.2): 2 mg/mL |
| Aggregatzustand | A solid |
| pKa (Säurekonstante) | 2.07±0.50(Predicted) |
| Farbe | Off-white to pink |
| Stabilität | Hygroscopic |
| InChI | 1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21) |
| InChIKey | RVGLGHVJXCETIO-UHFFFAOYSA-N |
| SMILES | Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O |
Sicherheit & Vorschriften
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
|---|---|
| Wassergefährdungsklasse (WGK) | WGK 3 |
| Lagerklasse | 11 - Combustible Solids |
Anwendungen & Verwendung
Verwenden
Lodoxamide is an antiallergic drug that acts as a mast cell stabilizer. It is effective in the treatment of allergic conjunctivitis and in decreasing vascular permeability.